drugset / Trial / NCT00378183

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

NCT00378183

Phase 4 Completed 120 enrolled Janssen, LP
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare three strategies for switching patients with schizophrenia or schizoaffective disorder to the atypical antipsychotic, risperdone, after they have been unsuccessfully treated with another atypical antipsychotic, olanzapine. In the second phase of this study, investigators will assess the effectiveness of behavioral therapy in reducing body weight in risperdone-treated patients who are overweight or have problems with diabetes or blood sugar.

Timeline

Start
2001-02
Primary completion
Completion
2002-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 1 mg Oral
Subject Risperidone Other / unclassified 2 mg Oral